Business strategy of nanofluidic chips for next-generation bioanalysis solutions to develop future medicines

Informazioni relative al progetto

Envue

ID dell’accordo di sovvenzione: 101113976

DOI

10.3030/101113976

Progetto chiuso

Data della firma CE 5 Giugno 2023

Data di avvio 1 Luglio 2023

Data di completamento 30 Aprile 2024

Finanziato da

• European innovation ecosystems

Costo totale

Nessun dato

Contributo UE

€ 75 000,00

Coordinato da

ENVUE TECHNOLOGIES AB
Sweden

Periodic Reporting for period 1 - Envue (Business strategy of nanofluidic chips for next-generation bioanalysis solutions to develop future medicines)

Periodo di rendicontazione: 2023-07-01 al 2024-04-30

Sintesi del contesto e degli obiettivi generali del progetto

This project focused on evaluating and enhancing our nanofluidic chip production process, refining our business model, and developing our intellectual property strategy. These efforts aimed to drive our technological innovation, foster sustainable growth, and strengthen global competitiveness for Envue.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

The work performed in this project consisted of three main parts:
(i) the nanofluidic chip production process,
(ii) business development, and business model,
(iii) intellectual property analysis and strategy,

Main achievements:
(i) successfully optimized nanofluidic chip production processes, achieving increased yield from 75% to 90%,
(ii) developed an updated business model that aligned better with market demands and findings,
(iii) conducted patent analyses and recommendations for an IP strategy forward.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The Women TechEU project has significantly advanced our nanofluidic chip production, refined business strategies, and strengthened intellectual property protections. This enhances our technological leadership and market position.
Key needs for further success include support for extensive product development, global commercialization, ongoing IP management, fundraising, and regulatory alignment.

Envue Nanofluidic Chip